Limits...
Osteosarcoma in Korean children and adolescents.

Lee JA - Korean J Pediatr (2015)

Bottom Line: Osteosarcoma is the most frequent primary bone tumor.The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients.This article provides an overview of current therapies for osteosarcoma in Korea.

View Article: PubMed Central - PubMed

Affiliation: Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea.

ABSTRACT
Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients. This article provides an overview of current therapies for osteosarcoma in Korea.

No MeSH data available.


Related in: MedlinePlus

The Korean Society of Pediatric Hematology and Oncology retrospective study: overall changes in the treatment and survival of children and adolescents with osteosarcoma. OS, overall survival. *Indicates the percentage of cases among those with tumors in the extremities.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4414626&req=5

Figure 3: The Korean Society of Pediatric Hematology and Oncology retrospective study: overall changes in the treatment and survival of children and adolescents with osteosarcoma. OS, overall survival. *Indicates the percentage of cases among those with tumors in the extremities.

Mentions: Fig. 3 shows the improvements made in osteosarcoma treatment over the past two decades. Currently, the treatment outcomes of Korean children and adolescents are comparable to those of American or European patients.


Osteosarcoma in Korean children and adolescents.

Lee JA - Korean J Pediatr (2015)

The Korean Society of Pediatric Hematology and Oncology retrospective study: overall changes in the treatment and survival of children and adolescents with osteosarcoma. OS, overall survival. *Indicates the percentage of cases among those with tumors in the extremities.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4414626&req=5

Figure 3: The Korean Society of Pediatric Hematology and Oncology retrospective study: overall changes in the treatment and survival of children and adolescents with osteosarcoma. OS, overall survival. *Indicates the percentage of cases among those with tumors in the extremities.
Mentions: Fig. 3 shows the improvements made in osteosarcoma treatment over the past two decades. Currently, the treatment outcomes of Korean children and adolescents are comparable to those of American or European patients.

Bottom Line: Osteosarcoma is the most frequent primary bone tumor.The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients.This article provides an overview of current therapies for osteosarcoma in Korea.

View Article: PubMed Central - PubMed

Affiliation: Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea.

ABSTRACT
Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients. This article provides an overview of current therapies for osteosarcoma in Korea.

No MeSH data available.


Related in: MedlinePlus